Related Experiment Videos
CD4 T lymphocyte activation in acute severe asthma
1Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, UK.
International Archives of Allergy and Applied Immunology
|January 1, 1991
Summary
CD4 T lymphocyte activation plays a key role in acute severe asthma (ASA). Researchers found higher levels of activation markers and specific proteins in asthma patients, which decreased with treatment, indicating their importance in ASA.
Area of Science:
- Immunology
- Respiratory Medicine
- Cell Biology
Background:
- Asthma is a chronic respiratory disease characterized by airway inflammation.
- The role of T lymphocyte activation in acute severe asthma (ASA) requires further elucidation.
Purpose of the Study:
- To investigate the expression of activation molecules on T lymphocytes in patients with ASA.
- To measure serum concentrations of interferon-gamma (IFN-gamma) and soluble interleukin-2 receptor (sIL-2R) in ASA patients.
Main Methods:
- Flow cytometry was used to analyze T lymphocyte activation markers (IL-2R, HLA-DR, VLA-1) on CD4+ and CD8+ cells.
- Serum levels of IFN-gamma and sIL-2R were quantified using immunoassays.
- Comparisons were made between patients with ASA and healthy controls.
Main Results:
- Patients with ASA showed significantly higher percentages of CD4+ T cells expressing IL-2R, HLA-DR, and VLA-1 compared to controls.
- Serum concentrations of IFN-gamma and sIL-2R were significantly elevated in ASA patients.
- These elevated markers decreased with clinical improvement following therapy.
Conclusions:
- CD4 T lymphocyte activation is implicated in the pathogenesis of acute severe asthma.
- Decreases in T lymphocyte activation markers correlate with clinical improvement in ASA.
- IFN-gamma and sIL-2R serve as potential biomarkers for ASA activity and treatment response.